Navigation Links
Vitamin Shots to Combat MS Pain

A recent study has revealed that vitamin shots may be beneficial in preventing severe long-term disability in multiple sclerosis patients.//

Presently there exists no effective treatment for the chronic progressive phase of MS, when serious disability is most likely to appear.

The Children's Hospital Boston study appearing in the Journal of Neuroscience, and conducted in mice showed that giving them a type of vitamin B3 known as nicotinamide cut the risk of nerve degeneration in mice with MS-type symptoms.

About 85,000 people in the UK, suffer from MS which is a disease of the central nervous system. The symptoms begin with the break down of the myelin sheath that coats nerve fibers, disrupting the ability to conduct electrical impulses to and from the brain.

Patients usually develop a form of the disease called relapsing-remitting MS, where outs of illness are followed by complete or partial recovery during which stage anti-inflammatory drugs can help.

However this stage is often followed by the chronic progressive phase, at which stage no effective treatment has been found.

The Boston team worked on mice with an MS-like disease called experimental autoimmune encephalitis (EAE).

The study revealed that daily nicotinamide shots protected the animals' nerve cells from myelin loss, stabilizing the condition of those cells that had already been affected. It was found that the greater the dose of nicotinamide, the greater the protective effect.

Rating disability on a scale of one to five, mice receiving the highest doses of nicotinamide scored between one and two, while animals who received no shots at all scored between three and four.

It was found that nicotinamide boosted levels of nicotinamide adenine dinucleotide (NAD), a vital chemical, in the animals' nervous systems.

In addition Nicotinamide also significantly reduced neurological deficits even wh en treatment was delayed until 10 days after the induction of EAE - raising hope that it will also be effective in the later stages of MS. Lead researcher Dr Shinjiro Kaneko said: "The earlier therapy was started, the better the effect, but we hope nicotinamide can help patients who are already in the chronic stage."

According to the researchers nicotinamide was cheap, and was considered to have few side effects. However, they said further work was needed to test its effect on humans.

Simon Gillespie, chief executive of the MS Society, said: "Any potential treatment for reducing the chronic progression of disability in MS deserves pursuing.

"This is interesting early research which we should like to see developed, adding our usual caution that what works in mice does not always work in men."

A spokesperson for the MS Trust said: "These are interesting results, but studies in mice with the experimental equivalent of MS may not necessarily translate into a successful treatment for people with MS."

Vitamin shots may help protect multiple sclerosis patients from severe long-term disability, a study suggests.

Currently, there is no effective treatment for the chronic progressive phase of MS, when serious disability is most likely to appear.


NLA
'"/>




Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... February 05, 2016 , ... Steven Tonkinson, 36, of Coconut Grove, ... year since it started in 2003. This year, he ran all 26.2 miles with ... and NBA team the Miami Heat. , This Sunday, while many are watching the ...
(Date:2/5/2016)... Minneapolis, MN (PRWEB) , ... February 05, 2016 , ... ... p.m. at the Day Block Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will ... , Larry Schneiderman, owner of Schneiderman’s Furniture, lives with Parkinson’s disease and is the ...
(Date:2/5/2016)... Toronto, Ontario (PRWEB) , ... February 05, 2016 , ... ... the Scarborough General Hospital Burn Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned ... the Scarborough Hospital. He successfully completed his first three-year term as chief and began ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: each ... longer to access the treadmills. It’s a predictable trend. After the excesses of November ... get in shape by joining gyms, starting new walking or running routines, or signing ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Dr. Justin Scott ... their 2nd Annual No Cost Dental Day to individuals in need. The event is ... of this No Cost Dental Day is to provide dental care to community members ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... announced the addition of the "Global ... financials" company profile to their offering. ... announced the addition of the "Global ... financials" company profile to their offering. ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology: